Observing naturopathic treatments for irritable bowel syndrome
Prospective Observational Study of Naturopathic Approaches to IBS
This study looks at how naturopathic treatments can help adults with irritable bowel syndrome feel better by tracking their symptoms and quality of life before and after treatment.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 50 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | National University of Natural Medicine Academic / other |
| Locations | 1 site (Portland, Oregon) |
| Trial ID | NCT06721624 on ClinicalTrials.gov |
What this trial studies
This study aims to explore how naturopathic medicine is utilized to treat irritable bowel syndrome (IBS) by collecting data on symptom changes before and after treatment. It will follow a prospective, observational design without a control group, focusing on individualized care provided by licensed naturopathic practitioners. Adult patients with diagnosed IBS or IBS-like symptoms will be recruited from affiliated naturopathic doctors, and their symptoms will be assessed using validated tools. The study will also measure quality of life and track any adverse events during the treatment process.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older with a diagnosed IBS or IBS-like gastrointestinal symptoms.
Not a fit: Patients who are unable to read and write in English will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide insights into effective naturopathic treatments for IBS, potentially improving patient outcomes and quality of life.
How similar studies have performed: While research on naturopathic approaches to IBS is limited, this study aims to fill a gap in understanding, making it a novel exploration in this area.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults (≥18 years of age) who present with a pre-existing IBS diagnosis or IBS- like gastrointestinal symptoms. * Pre-existing IBS diagnosis or IBS-like gastrointestinal symptoms must be the primary cause of the visit. * An IBS diagnosis must be listed within the top 3 diagnoses for the visit and addressed in the individualized treatment plan. Exclusion Criteria: \*Inability to read and write in English.
Where this trial is running
Portland, Oregon
- Helfgott Research Institute - National University of Natural Medicine — Portland, Oregon, United States (Recruiting)
Study contacts
- Study coordinator: Joshua Goldenberg, ND
- Email: jgoldenberg@nunm.edu
- Phone: 2068830119
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.